Lord, Abbett & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,260,707
| Closed | -$74.6M | – | 610 |
|
|
2021
Q3 | $74.6M | Sell |
1,260,707
-73,954
| -6% | -$4.87M | 0.18% | 175 |
|
|
2021
Q2 | $89.2M | Sell |
1,334,661
-1,332,022
| -50% | -$86.9M | 0.22% | 139 |
|
|
2021
Q1 | $168M | Buy |
2,666,683
+87,017
| +3% | +$5.41M | 0.43% | 49 |
|
|
2020
Q4 | $160M | Buy |
2,579,666
+69,438
| +3% | +$4.27M | 0.42% | 52 |
|
|
2020
Q3 | $151M | Sell |
2,510,228
-48,440
| -2% | -$2.92M | 0.48% | 41 |
|
|
2020
Q2 | $150M | Buy |
2,558,668
+1,649,915
| +182% | +$98.7M | 0.53% | 35 |
|
|
2020
Q1 | $50.7M | Buy |
+908,753
| New | +$55.5M | 0.22% | 133 |
|
|
2019
Q4 | – | Sell |
-552,800
| Closed | -$28M | – | 673 |
|
|
2019
Q3 | $28M | Sell |
552,800
-9,200
| -2% | -$432K | 0.1% | 342 |
|
|
2019
Q2 | $25.5M | Sell |
562,000
-156,721
| -22% | -$7.3M | 0.08% | 376 |
|
|
2019
Q1 | $34.3M | Buy |
718,721
+111,101
| +18% | +$5.53M | 0.11% | 292 |
|
|
2018
Q4 | $31.6M | Sell |
607,620
-23,148
| -4% | -$1.24M | 0.12% | 274 |
|
|
2018
Q3 | $39.2M | Sell |
630,768
-9,400
| -1% | -$558K | 0.11% | 319 |
|
|
2018
Q2 | $35.4M | Buy |
640,168
+85,688
| +15% | +$4.63M | 0.1% | 314 |
|
|
2018
Q1 | $35.1M | Sell |
554,480
-11,213
| -2% | -$721K | 0.1% | 305 |
|
|
2017
Q4 | $34.7M | Sell |
565,693
-27,989
| -5% | -$1.75M | 0.1% | 320 |
|
|
2017
Q3 | $37.8M | Sell |
593,682
-165
| -0% | -$9.63K | 0.11% | 297 |
|
|
2017
Q2 | $33.1M | Sell |
593,847
-12,300
| -2% | -$669K | 0.1% | 323 |
|
|
2017
Q1 | $33M | Sell |
606,147
-15,106
| -2% | -$829K | 0.1% | 317 |
|
|
2016
Q4 | $36.3M | Sell |
621,253
-96,826
| -13% | -$5.29M | 0.11% | 274 |
|
|
2016
Q3 | $38.7M | Sell |
718,079
-35,217
| -5% | -$2.26M | 0.12% | 270 |
|
|
2016
Q2 | $55.4M | Buy |
753,296
+310,628
| +70% | +$21.9M | 0.17% | 176 |
|
|
2016
Q1 | $28.3M | Sell |
442,668
-193,148
| -30% | -$12.2M | 0.09% | 340 |
|
|
2015
Q4 | $43.7M | Sell |
635,816
-30,050
| -5% | -$1.99M | 0.13% | 242 |
|
|
2015
Q3 | $39.4M | Buy |
665,866
+117,786
| +21% | +$7.47M | 0.12% | 272 |
|
|
2015
Q2 | $36.5M | Sell |
548,080
-1,368,285
| -71% | -$90.2M | 0.1% | 337 |
|
|
2015
Q1 | $124M | Sell |
1,916,365
-4,371,353
| -70% | -$274M | 0.31% | 75 |
|
|
2014
Q4 | $371M | Sell |
6,287,718
-1,544,945
| -20% | -$87.1M | 0.94% | 6 |
|
|
2014
Q3 | $401M | Buy |
7,832,663
+4,112,683
| +111% | +$205M | 1.01% | 5 |
|
|
2014
Q2 | $180M | Sell |
3,719,980
-878,434
| -19% | -$43.3M | 0.41% | 54 |
|
|
2014
Q1 | $239M | Buy |
4,598,414
+1,106,020
| +32% | +$58.9M | 0.54% | 19 |
|
|
2013
Q4 | $186M | Buy |
3,492,394
+461,383
| +15% | +$23.5M | 0.41% | 43 |
|
|
2013
Q3 | $140M | Buy |
3,031,011
+566,357
| +23% | +$24.9M | 0.32% | 69 |
|
|
2013
Q2 | $110M | Buy |
+2,464,654
| New | +$107M | 0.26% | 100 |
|
Other funds holding BMY
Lord, Abbett & Co's BMY Position: Q4 2021 in Review
Lord, Abbett & Co sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 1,260,707 shares — an estimated $74.6M sold.
Lord, Abbett & Co first reported a position in BMY in Q2 2013 and held it in 33 quarters. The position peaked at $401M in Q3 2014. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.
- Lord, Abbett & Co reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
- Lord, Abbett & Co sold 1,260,707 Bristol-Myers Squibb shares in Q4 2021, an estimated $74.6M.
- Lord, Abbett & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 33 quarters.
- Lord, Abbett & Co's Bristol-Myers Squibb position peaked at $401M in Q3 2014.
- 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.
Based on Lord, Abbett & Co's 13F filing for Q4 2021, filed 11 Feb 2022.